Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Different ethnic hair traits must be considered for successful hair restoration surgery to achieve natural-looking results.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Hair restoration for East Asians should consider their unique characteristics like head shape, hair thickness, and hair density, and use modified procedures and treatments to minimize scarring and maintain hair density.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Body hairs can be used in forensic science and toxicology like scalp hair.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

The book is an updated guide on hair transplant techniques, useful for beginners and professionals.

Hair camouflage techniques can help manage hair loss and boost confidence.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

A young child with alopecia areata and psoriasis improved with treatment, suggesting a link between the two conditions.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Early diagnosis of alopecia frontal fibrosante is crucial, but treatment remains controversial and varies.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Facebook groups play a crucial role in supporting and guiding patients on scalp cooling and hair loss during chemotherapy.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Genetic testing can help diagnose skin conditions but needs more research for full effectiveness.